Hormoz Ayramloo

Iranian Consensus Recommendations for Treatment of Myasthenia Gravis.

R. Boostani, F. Fatehi, S. Nafissi, 2022, Archives of Iranian medicine.

Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double‐blind, placebo‐controlled trial

Majid Ahmadi, Mehdi Yousefi, Leili Aghebati-Maleki, 2018, Journal of cellular physiology.

Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study

M. Sahraian, V. Shaygannejad, M. Etemadifar, 2021, Caspian journal of internal medicine.

Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double‐blind, placebo‐controlled trial

M. Nouri, M. Yousefi, F. Marofi, 2018, Journal of cellular physiology.